Regentis Biomaterials Ltd. (RGNT) stock
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$1.14−0.08 (-6.56%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Regentis Biomaterials total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Regentis Biomaterials's total debt was $1.20M at Dec 31, 2025. For fiscal 2025 it was $1.20M, up 108.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20M | +108.9% |
| FY2024 | Dec 31, 2024 | $573.00K | +172.9% |
| FY2023 | Dec 31, 2023 | $210.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $1.20M | – |
| Q4 FY2024 | Dec 31, 2024 | $573.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $210.00K | – |
See a number that looks wrong?